Women can ‘grow’ their own IVF embryos with in-body incubator
By Andy Coghlan,
New Scientist
| 01. 06. 2016
Untitled Document
KEEP them close. Women having IVF can now incubate embryos in their own bodies before they are implanted in the womb. Results from a clinical trial suggest the incubation device could work as well as conventional IVF and be far cheaper.
Cylindrical in shape, INVOcell is held in the vagina by a flexible diaphragm. The embryos are kept in an inner chamber at body temperature and gases such as carbon dioxide and oxygen diffuse in and out at levels matching natural fertilisation. After five days the embryos will have grown into balls of about 100 cells. The device is then removed and doctors choose the embryo that looks healthiest to implant.
In a US trial of 40 women, the device performed almost as well as conventional incubation, with 65 per cent of the women becoming pregnant regardless of the method used. Fifty-five per cent who used in-body incubation went on to give birth compared with 60 per cent who had the standard method. “We were very pleased with the results,” says Kevin Doody of the Center for Assisted...
Related Articles
By Grace Won, KQED [with CGS' Katie Hasson] | 12.02.2025
In the U.S., it’s illegal to edit genes in human embryos with the intention of creating a genetically engineered baby. But according to the Wall Street Journal, Bay Area startups are focused on just that. It wouldn’t be the first...
Several recent Biopolitical Times posts (1, 2, 3, 4) have called attention to the alarmingly rapid commercialization of “designer baby” technologies: polygenic embryo screening (especially its use to purportedly screen for traits like intelligence), in vitro gametogenesis (lab-made eggs and sperm), and heritable genome editing (also termed embryo editing or reproductive gene editing). Those three, together with artificial wombs, have been dubbed the “Gattaca stack” by Brian Armstrong, CEO of the cryptocurrency company...
By Lucy Tu, The Guardian | 11.05.2025
Beth Schafer lay in a hospital bed, bracing for the birth of her son. The first contractions rippled through her body before she felt remotely ready. She knew, with a mother’s pit-of-the-stomach intuition, that her baby was not ready either...
By Emily Glazer, Katherine Long, Amy Dockser Marcus, The Wall Street Journal | 11.08.2025
For months, a small company in San Francisco has been pursuing a secretive project: the birth of a genetically engineered baby.
Backed by OpenAI chief executive Sam Altman and his husband, along with Coinbase co-founder and CEO Brian Armstrong, the startup—called...